Molecular Vaccines From Prophylaxis to Therapy - Volume 2 [Hardcover]

This title discusses all aspects of non-infectious and non-cancer so called NINC  vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth. The book is therefore of interest for researchers and clinicians engaged in vaccine development and molecular vaccine application.This book examines all aspects of global molecular vaccine research and development. It describes the development of new vaccines from bench to preclinical to clinical studies and launch to the market under EMA and FDA guidelines.Non-infectious and non-cancer vaccines.- Adjuvants and nanotechnology.- In silico and delivery systems.- Patenting, manufacturing, registration.Dr. Matthias Giese, Heidelberg, GermanyThis title discusses all aspects of non-infectious and non-cancer so called NINC  vaccines. Hypertension, diabetes and allergy vaccine development are referred to as well as the use of adjuvants and nanotechnology in vaccine development. The way of novel vaccines from bench to preclinical to clinical studies and launch to the market under EMEA (European Medicines Agency) and FDA (Food and Drug Administration) guidelines are described in-depth.?Practical perspectives of patentability of vaccines are discussed.?The book is therefore of interest for researchers and clinicians engaged in vaccine development and molecular vaccine application.

Reviews aspects of NINC vaccine development

Illustrates the complete process of vaccine development from bench to preclinical and clinical studies and launch to the market

Enriches understanding of the use of nanotechnology in vaccine development

NL